Prosecution Insights
Last updated: April 19, 2026

Risen (Suzhou) Pharma Tech Co. Ltd.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18466473 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF LEE, CHIHYI NMN 1628 Non-Final OA Sep 13, 2023
18463439 KRAS INHIBITOR AND PHARMACEUTICAL USES THEREOF COPPINS, JANET L 1628 Non-Final OA Sep 08, 2023
18266331 PHARMACEUTICAL APPLICATION OF FUSED RING PHENOLIC COMPOUNDS GALSTER, SAMUEL LEONARD 1693 Non-Final OA Jun 09, 2023
18119592 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF LEE, CHIHYI NMN 1628 Non-Final OA Mar 09, 2023
18021709 CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF LEE, HOI YAN NMN 1693 Final Rejection Feb 16, 2023
17844407 BIVALENT COMPOUNDS, CONJUGATES AND USES THEREOF MCINTOSH III, TRAVISS C 1693 Final Rejection Jun 20, 2022

Managing Risen (Suzhou) Pharma Tech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month